LX9211
LX9211.1-201-DPN
Phase 2 small_molecule completed
Quick answer
LX9211 for Diabetic Peripheral Neuropathy is a Phase 2 program (small_molecule) at LEXICON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LEXICON PHARMACEUTICALS, INC.
- Indication
- Diabetic Peripheral Neuropathy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed